Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.46%NZDCHF+0.45%GBPTRY+0.41%USDCAD-0.39%EURCAD-0.35%GBPHKD+0.32%CADJPY+0.31%AUDSGD+0.31%GBPUSD+0.30%NZDSGD+0.30%GBPMXN-0.28%USDTRY+0.27%NZDUSD+0.27%CHFJPY-0.27%AUDUSD+0.26%USDNOK-0.26%EURCHF+0.25%EURGBP-0.23%NZDMXN+0.23%GBPJPY+0.22%USDZAR-0.21%USDCHF+0.20%GBPSGD+0.20%EURAUD-0.18%AUDJPY+0.18%NZDJPY+0.18%NOKJPY+0.17%EURNZD-0.17%EURNOK-0.16%USDILS+0.16%AUDDKK+0.16%CHFNOK-0.16%CHFSGD+0.16%NZDCAD-0.16%USDSEK-0.16%EURSGD+0.15%USDPLN-0.15%SGDJPY-0.14%AUDCAD-0.13%EURZAR-0.12%EURHKD+0.09%USDDKK-0.09%GBPZAR-0.08%GBPCAD-0.08%USDJPY-0.07%PLNJPY+0.07%EURSEK-0.07%EURCNH+0.06%CHFSEK-0.06%EURUSD+0.06%USDSGD+0.06%GBPAUD+0.06%EURPLN-0.06%USDCOP-0.04%GBPNZD+0.03%USDCNH-0.03%USDTHB+0.03%AUDNZD+0.02%USDMXN-0.01%EURJPY-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK0.00%EURDKK0.00%HG1+0.74%COTTON+0.71%S1+0.47%XNGUSD+0.32%W1-0.28%XAGUSD+0.26%GAGUSD+0.25%UKOIL-0.18%USOIL-0.16%XAUUSD+0.13%GAUUSD+0.13%XPTUSD+0.06%BTCUSD+2.39%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.57%DOGEUSD+14.12%XMRUSDT+5.80%LINKUSD+13.42%XLMUSD+0.27%BCHUSDT+5.89%UNIUSD+7.49%LTCUSD+9.66%SUIUSD+3.37%HBARUSDT+0.35%TONUSD+26.15%TAOUSDT+3.90%AAVEUSD+3.58%DOTUSDT-0.20%ICPUSDT+0.78%ONDOUSDT+0.36%WLDUSDT-0.02%ARBUSDT+6.66%JUPUSDT+0.62%ATOMUSDT+1.90%INJUSDT+13.30%STXUSDT+6.52%FETUSDT+2.74%TIAUSDT+9.19%PYTHUSDT-0.74%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+18.94%GRTUSDT+4.09%IOTAUSDT+0.88%WIFUSDT+2.70%AXSUSDT-1.83%POLUSDT+2.78%FARTCOINUSDT+0.63%EOSUSDT+2.70%DYDXUSDT+3.44%GALAUSDT-1.87%ORDIUSDT-0.09%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.46%NZDCHF+0.45%GBPTRY+0.41%USDCAD-0.39%EURCAD-0.35%GBPHKD+0.32%CADJPY+0.31%AUDSGD+0.31%GBPUSD+0.30%NZDSGD+0.30%GBPMXN-0.28%USDTRY+0.27%NZDUSD+0.27%CHFJPY-0.27%AUDUSD+0.26%USDNOK-0.26%EURCHF+0.25%EURGBP-0.23%NZDMXN+0.23%GBPJPY+0.22%USDZAR-0.21%USDCHF+0.20%GBPSGD+0.20%EURAUD-0.18%AUDJPY+0.18%NZDJPY+0.18%NOKJPY+0.17%EURNZD-0.17%EURNOK-0.16%USDILS+0.16%AUDDKK+0.16%CHFNOK-0.16%CHFSGD+0.16%NZDCAD-0.16%USDSEK-0.16%EURSGD+0.15%USDPLN-0.15%SGDJPY-0.14%AUDCAD-0.13%EURZAR-0.12%EURHKD+0.09%USDDKK-0.09%GBPZAR-0.08%GBPCAD-0.08%USDJPY-0.07%PLNJPY+0.07%EURSEK-0.07%EURCNH+0.06%CHFSEK-0.06%EURUSD+0.06%USDSGD+0.06%GBPAUD+0.06%EURPLN-0.06%USDCOP-0.04%GBPNZD+0.03%USDCNH-0.03%USDTHB+0.03%AUDNZD+0.02%USDMXN-0.01%EURJPY-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK0.00%EURDKK0.00%HG1+0.74%COTTON+0.71%S1+0.47%XNGUSD+0.32%W1-0.28%XAGUSD+0.26%GAGUSD+0.25%UKOIL-0.18%USOIL-0.16%XAUUSD+0.13%GAUUSD+0.13%XPTUSD+0.06%BTCUSD+2.39%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.57%DOGEUSD+14.12%XMRUSDT+5.80%LINKUSD+13.42%XLMUSD+0.27%BCHUSDT+5.89%UNIUSD+7.49%LTCUSD+9.66%SUIUSD+3.37%HBARUSDT+0.35%TONUSD+26.15%TAOUSDT+3.90%AAVEUSD+3.58%DOTUSDT-0.20%ICPUSDT+0.78%ONDOUSDT+0.36%WLDUSDT-0.02%ARBUSDT+6.66%JUPUSDT+0.62%ATOMUSDT+1.90%INJUSDT+13.30%STXUSDT+6.52%FETUSDT+2.74%TIAUSDT+9.19%PYTHUSDT-0.74%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+18.94%GRTUSDT+4.09%IOTAUSDT+0.88%WIFUSDT+2.70%AXSUSDT-1.83%POLUSDT+2.78%FARTCOINUSDT+0.63%EOSUSDT+2.70%DYDXUSDT+3.44%GALAUSDT-1.87%ORDIUSDT-0.09%RONINUSDT-3.42%NOTUSDT+1.21%
MO

Moderna, Inc. (MRNA)

NASDAQ • Healthcare

$216.25
+$2.5 (+1.2%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$207.63
Day Range$204.7 - $218.48
Avg. Volume (3M)17.5M
Market Cap$85.8B
52 Week Range
$22.28$227.46
Next EarningsIn 22 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$145M100%
Gross Profitminus cost of goods$52M36%

Fundamentals & Financials

Revenue (TTM)
$2.2B
Net Income (TTM)
-$3.1B
EPS (TTM)
-$7.98
ROA (TTM)
-28.75%
Current Ratio
2.29
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+16.9%Q1 2026-$2.11
+23.6%Q2 2026-$3.4
+3.0%Q3 2026-$1.97
Next

Nov 5

in 22 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +3.0%

Moderna’s EPS of -$1.97 topped the -$2.03 estimate, +3.0%, as revenue rose 2.1% to about $145.0 million in the second fiscal quarter of 2026, reported July 31. Revenue moved up from about $142.0 million a year ago, while operating income remained negative at about $815.0 million and net income came in as a loss of about $782.0 million, up 5.2% from a loss of about $825.0 million a year ago. The company also repurchased about $2.0 million of stock during the period. Consensus for the next period calls for EPS of -$1.38 on revenue of $872.9 million.

Next report — what to expect

Moderna, Inc. (MRNA) reports earnings on November 5, 2026. Wall Street expects EPS of -$1.10 on revenue of $894.8 million. For trailing context, revenue rose +2.1% year over year last quarter. Moderna has beaten EPS in 8 of 8 most recent quarters, making any change in that pattern a key focus.

View full earnings history

About Moderna, Inc.

Moderna, Inc. develops and commercializes messenger RNA medicines and vaccines as a biotechnology company in healthcare, with $1.9 billion in revenue in FY2025. Listed on the NASDAQ Global Select Market under MRNA, the company applies its mRNA platform to preventive vaccines as well as therapeutic programs across infectious disease, oncology, and other treatment categories.

Name
Moderna, Inc.
CEO
Stéphane Bancel
Website
www.modernatx.com
Industry
Healthcare
Year Founded
2010
Employees
4,700

Today's Snapshot

AI-generated

MRNA closed 1.2% higher at 216.25, outperforming a weaker sector. Shares changed hands at about two-thirds of its usual level. Moderna held its first-quarter fiscal 2026 earnings call.

Trading Volume

Below 10d avg (19.1M)

13.2M

vs S&P 500 Today

Outperforming Market

+1.19%

Updated: October 13, 2026 at 20:17 UTC

MRNA Headlines

Moderna to Join Nasdaq-100 Index

October 2, 2026

2 min read

Cancer vaccine data lifts biotech shares

September 13, 2026

3 min read

Moderna–Merck mRNA melanoma trial succeeds

August 22, 2026

3 min read

Arbutus plans US$230m share tender offer

August 21, 2026

3 min read
View All News

Technical Indicators

6 Buy1 Neutral1 Sell
MRNA, trading around 216.25, presents a strong buy profile underpinned by robust trend and momentum measures. ADX is very strong at about 62.7 and momentum indicators including MACD and a pronounced momentum reading confirm accelerating buying pressure, while virtually all moving averages from short to 200-day lie well below the market. Volume (OBV) is strongly positive, supporting the advance, although volatility is elevated with ATR roughly 15.18. Technical takeaway: Strong Buy — broad-based trend and momentum dominate despite elevated volatility.
All signals
  • EMA (5 indicators)$86.75 - $203.36
    Buy
  • RSI (14)66.34
    Neutral
  • Stochastic %K (14, 3, 3)82.35
    Sell
  • MACD Level (12, 26)19.15
    Buy

Peers & Related Assets

PFEPfizer Inc.
$28.37-0.1%
BNTXBioNTech SE
$89.01-7.1%
PCVXVaxcyte, Inc.
$66.76-5.5%
NVAXNovavax, Inc.
$12.82+1.3%
VIRVir Biotechnology, Inc.
$10.61-6.1%
ARCTArcturus Therapeutics Holdings Inc.
$12.03-4.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.